How does the old saying go? Beggars can't be choosers? Two weeks ago, yours truly penned some bullish comments regarding OncoSec Medical Inc. (OTCMKTS:ONCS). The long and short of it was, if ONCS could clear a technical ceiling around $0.36, then life would get much easier for the bulls.
Well, the good news is, ONCS did it...just today, in fact. The bad news is, OncoSec Medical cleared the hurdle in such as way as to create another problem. Specifically, the move itself has created some bearish pressure that may well undo the breakout move before it has a chance to go anywhere. Fear not, however. Even if the stock does pull back, the bulls have tipped their hand and it's most likely a mater of when rather than if the stock rekindles the uptrend that was jump-started today.
For those not familiar, OncoSec Medical Inc. is the developer of a drug-delivery approach and system that uses electroporation to deposit a chemical/molecular therapy more precisely where an ailment or illness is growing in a patient's body. Specifically, electroporation essentially opens up - makes more porous - an infected or cancerous cell so that medicine has an easier time of entering it and killing the disease. To date, ONCS has primarily used cancer drug bleomycin as a tumor-killing agent for patients that have undergone the electroporation process, and the results have been highly encouraging. In fact, today's pop from the stock was sparked by another dose of good news for the electroporation approach using a different cancer agent on a different kind of cancer. It all points in the same positive direction, however.
Top 5 Gas Utility Stocks To Invest In 2015: Cree Inc.(CREE)
Cree, Inc. develops and manufactures light emitting diodes (LEDs), LED lighting, and semiconductor solutions for wireless and power applications. Its LED products include blue and green LED chips that are used in various applications, including video screens, gaming displays, function indicator lights, and automotive backlighting; LED components comprising a range of packaged LED products and LED modules for lighting applications; LED lighting products, such as LED downlights, LED troffers, and LED lamps or bulbs for construction, retrofit, and renovation projects in commercial, governmental, and residential applications; and silicon carbide (SiC) wafers, which are used in the manufacture of optoelectronics, microwave, power switching, and other applications. The company also provides semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN), and related compounds. Its power and radio frequency (RF) products include SiC-based power products comprising 600, 1,200, and 1,700-volt Schottky diodes, as well as 1,200-volt SiC metal semiconductor field-effect transistor switches that are used in power factor correction circuits for power supplies in computer servers and other applications, such as solar inverters; and RF devices, including a range of GaN high electron mobility transistors and monolithic microwave integrated circuits for military or commercial applications, as well as 10 watt and 60 watt SiC transistors and metal semiconductor field effect transistor products. The company primarily operates in China, the United States, Europe, South Korea, Japan, Malaysia, and Taiwan. Cree, Inc. was formerly known as Cree Research, Inc. and changed its name in January 2000. Cree, Inc. was founded in 1987 and is based in Durham, North Carolina.
Advisors' Opinion:- [By Seth Jayson]
Cree (Nasdaq: CREE ) reported earnings on April 23. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q3), Cree beat slightly on revenues and met expectations on earnings per share. - [By rusticnomad]
After more than a year when an outperformance rating was given on Cree (CREE), it has turned out to be an overachiever with 112% returns. Cree is a LED lighting company which has always focused on delivering the best performance at the lowest cost.
Top 5 Gas Utility Stocks To Invest In 2015: Bridgeline Digital Inc.(BLIN)
Bridgeline Digital, Inc. engages in the development of Web experience management (WEM) product and interactive technology solutions that help organizations to optimize business processes. Its iAPPS product suite includes iAPPS Content Manager that allows non-technical users to create, edit, and publish content through a browser-based interface; iAPPS Commerce, an online B2B and B2C eCommerce solution, which allows users to maximize and manage various aspects of commerce initiatives; and iAPPS Marketier, a marketing lifecycle management solution that comprises customer transaction analysis, email management, surveys and polls, event registration, and issue tracking to measure campaign return on investment and client satisfaction. The company also provides iAPPS Analyzer to manage, measure, and optimize Web properties by recording detailed events and mine data within a Web application for statistical analysis; and iAPPS Rapid Site for building custom Websites. It delivers it s iAPPS product suite through cloud-based software as a service business model or via a traditional perpetual licensing business model. The company?s end-to-end interactive technology solutions consist of digital strategy, user-centered design, Web application development, SharePoint development, rich media development, search engine optimization, and Web application hosting management. Bridgeline Digital serves various markets, such as financial services, consumer products and goods, health services and life sciences, high technology (software and hardware), retail brand names, transportation and storage, associations and foundations, and the U.S. Government through its direct sales force. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is based in Burlington, Massachusetts.
Advisors' Opinion:- [By Bryan Murphy]
Congratulations to anyone who owned shares of Bridgeline Digital Inc. (NASDAQ:BLIN) before today. You're now up 35% for the day so far, and still counting. The big pop from BLIN stemmed from the announcement that it scored a pretty significant deal with an organization consisting of nearly 4000 dentists and doctors. The terms of the deal are simple enough... Bridgeline Digital will host and service websites for the practitioners in the group for a period of three years, and in return, BLIN will receive $7 million.
Hot Prefered Stocks To Own For 2015: Chorus Ltd (CNU)
Chorus Limited maintains and builds a network made up of local telephone exchanges, cabinets and copper and fiber cables. The Company has approximately 32,000 kilometers of fiber and 130,000 kilometers of copper cabling. These cables connect back to local telephone exchanges. Chorus fiber also connects mobile phone towers owned by mobile service providers. About 7,000 cabinets provide interconnection points for around 50% of the lines in its network. A range of these cabinets are mini telephone exchanges and have electronic broadband equipment installed in them. In some cases, retail service providers have chosen to install their own broadband equipment in an exchange and pay the Company for the rental of the access line. It offers a range of products delivered over its copper network and new products designed to provide access to the ultra-fast broadband (UFB) fiber network. Advisors' Opinion:- [By Holly LaFon]
Watsa sold two stocks in the fourth quarter: Continucare Corp. (CNU) and First Place Financial Corp. (FPFC). He reduced Dell (DELL), one of his largest holdings, but almost 60%.
Top 5 Gas Utility Stocks To Invest In 2015: Athersys Inc.(ATHX)
Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States. Its clinical development programs are focused on treating cardiovascular disease, neurological conditions, inflammatory and immune disorders, and other conditions. Its product pipeline includes MultiStem, a novel allogeneic approach to stem cell therapy and regenerative medicine for treating a range of diseases. The company is also involved in the development of novel small molecule compounds for applications in indications, such as obesity and other areas, including the treatment of neurological conditions, and for the modulation of stem cells or related applications in the regenerative medicine area. It has product co-development collaboration with Pfizer Inc. to develop and commercialize MultiStem to treat inflammatory bowel disease for the worldwide market; Angiotech Pharmaceuticals, Inc. to develop and commerciali ze MultiStem to treat certain cardiovascular diseases, such as acute myocardial infarction; and RTI Biologics, Inc. to develop and commercialize biologic implants for certain orthopedic applications in the bone graft substitutes market. The company was founded in 1995 and is based in Cleveland, Ohio.
Advisors' Opinion:- [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]
Biotechnology company Athersys Inc.(ATHX) said interim results of a mid-stage study of its MultiStem cell therapy for ulcerative colitis failed to show meaningful benefit in certain cases, though the treatment had favorable safety and tolerability. Shares plunged 52% to $1.30 premarket.
- [By Sean Williams]
What: Shares of Athersys (NASDAQ: ATHX ) , a clinical-stage biotechnology company focused on regenerative medicine, advanced as much as 10% after announcing that it had been granted three new patents for its stem cell and regenerative technologies in Japan.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are 3M Co.(MMM), Boeing Co.(BA) and Athersys Inc.(ATHX)
3M raised its quarterly dividend by 35%, as the company continued its effort to consistently boost its payouts to shareholders. 3M–whose products include Scotch tape, Nexcare bandages and Post-it Notes–is known as a reliable profit machine. Dividends have increased annually in each of the past 55 years. Shares rose 2.8% to $131 premarket.
Top 5 Gas Utility Stocks To Invest In 2015: Reynolds American Inc(RAI)
Reynolds American Inc. (RAI), through its subsidiaries, manufactures and sells cigarette and other tobacco products in the United States. It offers cigarettes under the brand names of CAMEL, PALL MALL, WINSTON, KOOL, DORAL, SALEM, MISTY, and CAPRI; and cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand name, as well as manages various licensed brands, including DUNHILL and STATE EXPRESS 555. The company also provides smokeless tobacco products, including moist snuff under GRIZZLY and KODIAK brand names; pasteurized tobacco under CAMEL Snus brand name; milled tobacco under the brand name of CAMEL Dissolvables; other tobacco products, such as little cigars under WINCHESTER and CAPTAIN BLACK brand names; and roll-your-own tobacco under the brand name of BUGLER. RAI sells its products primarily through distributors, wholesalers, and other direct customers, including retail chains, as well as distributes its cigarettes to public warehouses. The compan y was founded in 1875 and is headquartered in Winston-Salem, North Carolina.
Advisors' Opinion:- [By Jim Royal]
If you need a reason to avoid America's big tobacco companies Altria (NYSE: MO ) and Reynolds American (NYSE: RAI ) , the recently proposed budget by President Obama might just be enough. The new budget proposes nearly doubling the federal tax rate from $1.01 to $1.95 per pack.
- [By Keith Fitz-Gerald]
Folks who've held Kinder Morgan Energy Partners LP (NYSE: KMP) or Reynolds American Inc. (NYSE: RAI) over the same time frame have seen total returns of 1,578% and 3,311%, respectively - with returns from dividends far exceeding capital gains in both cases.
- [By GuruFocus]
The decade low yield of tobacco stocks can be clearly seen from our new interactive charts, which are embedded below. The chart shows the dividend yield of three tobacco stocks: Reynolds American (RAI), Philip Morris International (PM) and British American Tobacco (BTI).
- [By Dan Caplinger]
As I observed earlier this week, the entire cigarette industry has been under siege from regulatory and public health authorities. Altria's rivals Reynolds American (NYSE: RAI ) and Lorillard (NYSE: LO ) were able to defeat an FDA proposal to force them to show graphic warnings on cigarette packs, but between negative ad campaigns and new attempts to eliminate tobacco display cases in New York City stores, Altria isn't getting any help in fighting a long-term trend of declining U.S. cigarette volume.
No comments:
Post a Comment